TP53BP1 and prostate cancer: Supportive to our model, we reported a much slower replication rate in different prostate cancer cells upon treatment by either 6-TB or 7-TB, leading to accumulation of pan-nuclear γH2AX staining and later to accumulation of DSBs as evidenced by increased number of 53BP1 foci.